AlloVir, Inc. Announces 2024 Annual Meeting of Stockholders

TL;DR

<b>AlloVir, Inc. invites stockholders to its 2024 Annual Meeting on June 6, 2024, to elect directors and ratify auditors, with voting accessible online.</b>

AI Summary

Allovir, Inc. (KLRS) filed a Proxy Statement (DEF 14A) with the SEC on April 23, 2024. AlloVir, Inc. will hold its 2024 Annual Meeting of Stockholders online on June 6, 2024, at 9:00 a.m. Eastern Time. The meeting agenda includes the election of three Class I directors for a three-year term. Stockholders will vote on the ratification of Deloitte & Touche LLP as the independent registered public accounting firm for fiscal year ending December 31, 2024. Proxy materials are accessible via the Internet at www.proxyvote.com. Stockholders can vote over the Internet, by telephone, or by mail using the proxy card.

Why It Matters

For investors and stakeholders tracking Allovir, Inc., this filing contains several important signals. The annual meeting is a key event for shareholders to exercise their voting rights on important corporate governance matters, including director elections and auditor ratification. The shift to a virtual meeting format and internet-based proxy material access reflects modern corporate practices for shareholder engagement and cost efficiency.

Risk Assessment

Risk Level: low — Allovir, Inc. shows low risk based on this filing. The filing is a routine proxy statement for an annual meeting and does not contain new financial or operational disclosures that would indicate significant risk.

Analyst Insight

Stockholders should review the proxy statement and vote on the proposed director nominees and auditor ratification before the June 6, 2024 meeting.

Key Numbers

• 3 — Class I directors (Number of directors to be elected for a three-year term.)
• 2024 — Fiscal Year End (Fiscal year for which the independent auditor is being ratified.)

Key Players & Entities

• AlloVir, Inc. (company) — Registrant and filer of the proxy statement.
• Deloitte & Touche LLP (company) — Proposed independent registered public accounting firm.
• June 6, 2024 (date) — Date of the 2024 Annual Meeting of Stockholders.
• 2024 (date) — Fiscal year for which Deloitte & Touche LLP is proposed to be appointed.

FAQ

Risk Factors

• Compliance with SEC Proxy Rules [low — regulatory]: The company must comply with all SEC rules and regulations regarding the filing and distribution of proxy materials.

Industry Context

AlloVir, Inc. is a biotechnology company focused on developing allogeneic T-cell therapies. This filing pertains to its annual shareholder meeting, a standard corporate governance event.

Regulatory Implications

The filing is made under Section 14(a) of the Securities Exchange Act of 1934, which governs the solicitation of proxies.

What Investors Should Do

1. Review the proxy statement for details on director nominees and auditor ratification.
2. Vote your shares either online, by phone, or by mail before the June 6, 2024 meeting.
3. Attend the virtual meeting on June 6, 2024, to participate and ask questions.

Key Dates

• 2024-06-06: 2024 Annual Meeting of Stockholders — Key date for shareholder voting on corporate matters.

Glossary

Proxy Statement

A document filed with the SEC that provides shareholders with information about matters to be voted on at a shareholder meeting. (Essential for shareholders to make informed voting decisions.)

Independent Registered Public Accounting Firm

A firm hired to audit the company's financial statements. (Ensures the accuracy and reliability of financial reporting.)

Year-Over-Year Comparison

This is a Definitive Proxy Statement (DEF 14A) filed for the 2024 Annual Meeting, indicating a routine annual corporate governance event.

Key Financial Figures

• $1.235 billion — which we have annual gross revenues of $1.235 billion or more, (3) the date that we become a
• $1.0 billion — date on which we have issued more than $1.0 billion in non-convertible debt during the prec
• $700 million — ck held by non-affiliates was less than $700 million and our annual revenue was less than $1
• $100 million — on and our annual revenue was less than $100 million during our most recently completed fisc
• $250 million — ock held by non-affiliates is less than $250 million or (ii) our annual revenue was less tha

Filing Documents

• d621337ddef14a.htm (DEF 14A) — 354KB
• g621337dsp043.jpg (GRAPHIC) — 68KB
• g621337dsp044.jpg (GRAPHIC) — 69KB
• g621337g09i09.jpg (GRAPHIC) — 28KB
• 0001193125-24-106976.txt (&nbsp;) — 583KB

From the Filing

DEF 14A 1 d621337ddef14a.htm DEF 14A DEF 14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant Filed by a party other than the Registrant Check the appropriate box: Preliminary Proxy Statement Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) Definitive Proxy Statement Definitive Additional Materials Soliciting Material Pursuant to 240.14a-12 AlloVir, Inc. (Name of Registrant as Specified In Its Charter) (Name of Person(s) Filing Proxy Statement, if Other Than The Registrant) Payment of Filing Fee (Check all boxes that apply): No fee required. Fee paid previously with preliminary materials Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11. April 23, 2024 Dear Stockholder: You are cordially invited to attend the 2024 Annual Meeting of Stockholders of AlloVir, Inc. (the Company or AlloVir). The meeting will be held online on June 6, 2024 at 9:00 a.m., Eastern Time. You may attend the meeting virtually via the Internet at www.virtualshareholdermeeting.com/ALVR2024, where you will be able to vote electronically and submit questions. You will need the 16-digit control number, which is located on the Notice of Internet Availability that you received in the mail, on your proxy card or in the instructions accompanying your proxy materials, to attend the Annual Meeting. Details regarding admission to the meeting and the business to be conducted are more fully described in the accompanying Notice of Annual Meeting and Proxy At this Annual Meeting, the agenda includes the election of three Class I directors for a three-year term, the ratification of the appointment of Deloitte & Touche LLP as the Companys independent registered public accounting firm for the fiscal year ending December 31, 2024, and to transact any other business that properly comes before the Annual Meeting. Under Securities and Exchange Commission rules, the Company is providing access to the proxy materials for the Annual Meeting to shareholders via the Internet. Accordingly, you can access the proxy materials and vote at www.proxyvote.com. Instructions for accessing the proxy materials and voting are described below and in the Notice of Annual Meeting that you received in the mail. Your vote is very important. Whether or not you plan to attend the meeting, please carefully review the enclosed proxy statement and then cast your vote, regardless of the number of shares you hold. If you are a stockholder of record, you may vote over the Internet, by telephone, or, if you request to receive a printed set of the proxy materials, by completing, signing, dating and mailing the accompanying proxy card in the return envelope. Submitting your vote via the Internet or by telephone or proxy card will not affect your right to vote online during the virtual meeting if you decide to attend the Annual Meeting. If your shares are held in street name (held for your account by a broker or other nominee), you will receive instructions from your broker or other nominee explaining how to vote your shares, and you will have the option to cast your vote by telephone or over the Internet if your voting instruction form from your broker or nominee includes instructions and a toll-free telephone number or Internet website to do so. In any event, to be sure that your vote will be received in time, please cast your vote by your choice of available means at your earliest convenience. We hope that you will join us on June 6, 2024. Your investment and continuing interest in the Company are very much appreciated. Sincerely, /s/ Diana Brainard Diana Brainard Chief Executive Officer NOTICE OF 2024 ANNUAL MEETING OF STOCKHOLDERS Time 9:00 a.m., Eastern Time Date Thursday, June 6, 2024 Place Online at www.virtualshareholdermeeting.com/ALVR2024 Purpose To elect each of Juan Vera, M.D., Morana Jovan-Embiricos, Ph.D. and Derek Adams, Ph.D. as a Class I member of the board of directors, to serve until the Companys 2027 Annual Meeting of Stockholders and until his successor is duly elected and qualified; To ratify the selection of Deloitte & Touche LLP as the Companys independent registered public accounting firm for the fiscal year ending December 31, 2024; and To transact any other business that may properly come before the meeting or any adjournment thereof. Record Date The board of directors has fixed the close of business on April 15, 2024 as the record date for determining stockholders entitled to notice of and to vote at the meeting. Meeting Admission All stockholders as of the record date, or their duly appointed proxies, may attend the meeting. In order to be able to attend the meeting, you will need the 16-digit control number, which is located on your Notice,

View Full Filing

View this DEF 14A filing on SEC EDGAR